Testing for the enzyme long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) is recommended because some babies from women with AFLP carry the metabolic disease of beta oxidation, and testing the baby is preferred; if not possible, the mother is tested, as she is potentially heterozygous. The gene discussed is HADHA; the disease is Other metabolic disease.